Clinical Trials Browser

Interventional × Carcinoma, Renal Cell × sintilimab × Clear all

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Sintilimab in FH-deficient Renal Cell Carcinoma